Exercise Influence on COVID-19

November 9, 2020 updated by: CARLOS MARTIN SANCHEZ, University of Salamanca

"Influence of Physical Exercise on the Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19"

An observational study is carried out in the university population of the University of Salamanca to know the impact of the COVID-19 pandemic and the influence of physical exercise on the severity of symptoms.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

  • Investigate the relationship between the regular practice of moderate physical exercise and the severity of the COVID-19 disease in the university community of the University of Salamanca.
  • Prepare an epidemiological study of the impact of the pandemic at the University of Salamanca.
  • Analyze the influence of the pandemic on the sports habits of the university community.
  • The study population will be the entire university community (teaching and research staff, administration and services staff, and students) who will be contacted via email.

Study Type

Observational

Enrollment (Anticipated)

30000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: CARLOS MARTIN-SANCHEZ, DOCTOR
  • Phone Number: +34646774655
  • Email: carlos_ms@usal.es

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 85 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

University of Salamanca population, which includes:

  • Teaching and research staff
  • Administration and services staff
  • Students

Description

Inclusion Criteria:

  • University of Salamanca population
  • Complete the survey

Exclusion Criteria:

  • Survey not filled out completely

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
University population
Survey to analyze the impact of COVID-19.
Diagnostic test: COVID-19 survey
Participants should complete a survey to analyze the impact of COVID-19 on University population.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of COVID-19
Time Frame: Through study completion, an average of 3 months
Number of positives
Through study completion, an average of 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Influence of exercise in COVID-19 infection
Time Frame: Through study completion, an average of 3 months
Quantity of physical exercise
Through study completion, an average of 3 months
Change in the practice of physical exercise after home confinement
Time Frame: Through study completion, an average of 3 months
Change at exercise habits on University population
Through study completion, an average of 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Salamanca

Investigators

  • Principal Investigator: CARLOS MARTIN-SANCHEZ, DOCTOR, University of Salamanca

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 4, 2020

Primary Completion (Anticipated)

January 4, 2021

Study Completion (Anticipated)

April 4, 2021

Study Registration Dates

First Submitted

November 8, 2020

First Submitted That Met QC Criteria

November 9, 2020

First Posted (Actual)

November 10, 2020

Study Record Updates

Last Update Posted (Actual)

November 12, 2020

Last Update Submitted That Met QC Criteria

November 9, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 08112020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

It will be decided when the recruitment period ends.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on COVID-19 survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe